Skip to content

Comparison of Two Pain-treatment Techniques After Tympanomastoid Surgery Pain

Ultrasound Guided Superficial Cervical Plexus Block Versus Greater Auricular Nerve Block for Tympanomastoid Surgery Pain

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03277599
Enrollment
50
Registered
2017-09-11
Start date
2016-07-05
Completion date
2017-07-07
Last updated
2018-03-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Nerve Block, Pain Management, Ultrasound

Brief summary

Analgesia following tympanomastoid surgery is critical for the prevention of postoperative . There are very few regional anesthesia methods used to achieve this goal.

Detailed description

In this study, it was aimed to investigate the effect of Ultrasound guided superficial cervical plexus block versus greater auricular nerve block for on postoperative tympanomastoid surgery analgesia.

Interventions

Tramadol infusion (PCA): 400 mg tramadol, IV 4 mg/mL tramadol solution into 100 mL normal saline; PCA settings: 0.3 mg/kg bolus, 10 mg Demand dose and 20 min lock out interval, six-hour limit infusion to attain 100 mg. Maximum daily dose was set at 400 mg.

ultrasound guided superficial cervical plexus blockage with 10 ml % 0.25 bupivacaine

DRUGultrasound guided Great Auricular nerve block

ultrasound guided Great Auricular nerve blockage with 5 ml % 0.25 bupivacaine +IV patient-controlled analgesia (PCA) tramadol

Sponsors

Bursa Yuksek Ihtisas Training and Research Hospital
Lead SponsorOTHER_GOV

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Intervention model description

prospective,randomized,single blind

Eligibility

Sex/Gender
ALL
Age
20 Years to 70 Years
Healthy volunteers
No

Inclusion criteria

* Patients who were in the American Society of Anesthesiologists (ASA) I-III class and underwent Tympanomastoid surgery.

Exclusion criteria

* Previous history of opioid use preoperatively, * Allergy to local anesthetics, * The presence of any systemic infection, * Uncontrolled arterial hypertension, * Uncontrolled diabetes mellitus.

Design outcomes

Primary

MeasureTime frameDescription
Visual Analog Pain ScalePostoperative 24 hoursVisual Analog Pain Scale was used for pain

Secondary

MeasureTime frameDescription
tramadol consumptionPostoperative 24 hourtramadol consumption
side effect profilePostoperative 24 hourside effect profile (including nausea and vomiting, hypotension,requirement and the Ramsay Sedation Scale (RSS) scores)
additional analgesic usePostoperative 24 houradditional analgesic use

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026